Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-016170
Filing Date
2025-06-23
Accepted
2025-06-23 19:34:56
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3065
  Complete submission text file 0001641172-25-016170.txt   4667
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Issuer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O THARIMMUNE, INC. 1200 ROUTE 22 EAST, SUITE 2000 BRIDGEWATER NJ 08807
Business Address
Parikh Sanam (Reporting) CIK: 0002046430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41210 | Film No.: 251066327